In my last article, published on Sept. 7, I discussed a hypothetical, startup biotech company called BioTech, which was founded by Joe Smith in Prince-ton. Here, I will focus on Joe and Jane’s quest for capital as they begin the research and development phase of manufacturing their prosthetic limb, which they hope will be more lifelike and cost-effective than any other previous prosthetic. This article will outline the law involving private placements of securities under Regulation D.
(This illustration is meant to be hypothetical, should not be condoned as legal advice and all references to businesses and individuals are coincidental.)
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
